Floatz logo

Therapeutic Asset Ratings

5,108 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Pirtobrutinib
Lymphoid Leukemia
Loxo Oncology, Inc.P3BB (66)
Pirtobrutinib
B-Cell Chronic Lymphocytic Leukemia
Newave Pharmaceutical IncP3BB (66)
Pirtobrutinib
Richter Transformation
SWOG Cancer Research NetworkP3BB (66)
Pralatrexate
Angioimmunoblastic T-Cell Lymphoma
Corvus Pharmaceuticals, Inc.P3BB (66)
Prednisolone
Down Syndrome
National Cancer Institute (NCI)P3BB (66)
Prednisone
Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-JosephP3BB (66)
Prednisone
B-Cell Acute Lymphoblastic Leukemia
University of WashingtonP3BB (66)
Prednisone
Hypogonadism
SWOG Cancer Research NetworkP3BB (66)
Prednisone
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
Prednisone
Renal Cell Carcinoma
ExelixisP3BB (66)
Prednisone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3BB (66)
Prednisone
Richter Transformation
SWOG Cancer Research NetworkP3BB (66)
Prednisone
Splenic Marginal Zone Lymphoma
SWOG Cancer Research NetworkP3BB (66)
Procarbazine
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P3BB (66)
Rap-219
Focal Epilepsy
Rapport Therapeutics Inc.P3BB (66)
Realgar-Indigo Naturalis Formulation
Acute Promyelocytic Leukemia
Instituto do Cancer do Estado de São PauloP3BB (66)
Regorafenib
Colon Adenocarcinoma
City of Hope Medical CenterP3BB (66)
Relatlimab
Cutaneous Melanoma
University Health Network, TorontoP3BB (66)
Resiniferatoxin
Osteoarthritis, Knee
Sorrento Therapeutics, Inc.P3BB (66)
Retatrutide
Chronic Kidney Disease
Eli Lilly and CompanyP3BB (66)
Ribociclib
Luminal B Breast Carcinoma
Danish Breast Cancer Cooperative GroupP3BB (66)
Rifaximin
Small Intestinal Bacterial Overgrowth
I.M. Sechenov First Moscow State Medical UniversityP3BB (66)
Risperidone
Depressive Disorder
University of ChicagoP3BB (66)
Risperidone Ism®
Schizophrenia
Rovi Pharmaceuticals LaboratoriesP3BB (66)
Rituximab
High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement
National Cancer Institute (NCI)P3BB (66)
Showing 1301 to 1325 of 5,108 assets
PreviousPage 53 of 205Next